TAKEDA PHARMACEUTICALS INTERNATIONAL AG

Forschungsprojekte

• Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer…